NCT03345914 · Interventional trial
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
Overall registry status Completed
Phase 3
Conditions Dermatitis, Atopic
Delaware Valley sites
- Regeneron Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory